Skip to main content
. 2017 Nov 18;8(62):105957–105970. doi: 10.18632/oncotarget.22515

Figure 2. Cox regression analysis of event-free survival based on gender and systemic symptoms.

Figure 2

Cox regression analysis shows patients carrying +3027 HLA-G polymorphism show lower EFS in (A) female and (B) systemic B symptomatic patients.